|
WO2002008288A2
(fr)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
EP2333069A3
(fr)
|
1998-05-15 |
2011-09-14 |
Genentech, Inc. |
Utilisations therapeutiques de polypeptides homologues de il-17
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
|
CA2361396A1
(fr)
*
|
1999-02-25 |
2000-08-31 |
Carlo M. Croce |
Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
EP1157038A4
(fr)
*
|
1999-02-26 |
2005-01-19 |
Smithkline Beecham Corp |
Clonage du recepteur 7tm (axor 17) du type p2y
|
|
AU3885400A
(en)
*
|
1999-03-23 |
2000-10-09 |
Human Genome Sciences, Inc. |
48 human secreted proteins
|
|
CA2365601A1
(fr)
|
1999-03-29 |
2000-10-05 |
Kansai Technology Licensing Organization Co., Ltd. |
Nouvelle cytidine desaminase
|
|
EP1621620A3
(fr)
*
|
1999-09-01 |
2006-05-10 |
Genetech, Inc. |
Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
|
|
WO2001030971A2
(fr)
*
|
1999-10-27 |
2001-05-03 |
Millennium Pharmaceuticals, Inc. |
Nouvelles molecules de la famille des proteines se rapportant aux card et leurs utilisations
|
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
|
EP1878795A3
(fr)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions et procédés pour le traitement de maladies liées au système immunitaire
|
|
EP2228446A1
(fr)
*
|
1999-12-01 |
2010-09-15 |
Genentech, Inc. |
Polypeptides secrétés et transmembranaires et acides nucléiques codant pour ceux-ci
|
|
CN1300781A
(zh)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
WO2001055391A2
(fr)
|
2000-01-26 |
2001-08-02 |
Agensys, Inc |
84p2a9: proteine specifique de la prostate et du testicule fortement exprimee dans le cancer de la prostate
|
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
|
US20020031815A1
(en)
*
|
2000-06-26 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
46619, a novel human beta-ketoacyl synthase and uses thereof
|
|
US20020055159A1
(en)
*
|
2000-06-15 |
2002-05-09 |
Meyers Rachel A. |
23680,a novel human aminotransferase and uses therefor
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
JP2003527860A
(ja)
*
|
2000-03-23 |
2003-09-24 |
イミューソル インコーポレイテッド |
Ｂｒｃａ−１制御因子およびその使用方法
|
|
AU2001245974A1
(en)
|
2000-03-24 |
2001-10-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
|
JP2004511205A
(ja)
|
2000-04-25 |
2004-04-15 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼプロテインおよびそれをコードするポリヌクレオチド
|
|
EP1280917A2
(fr)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, deshydrogenase humaine a chaine courte et ses utilisations
|
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
|
EP1278863A2
(fr)
*
|
2000-05-12 |
2003-01-29 |
MERCK PATENT GmbH |
Nouvelle serine-threonine kinase-4
|
|
EP1158001B1
(fr)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
Un acide nucléique produit excessivement dans des cellules tumorales humaines, une protéine codée par ledit acide nucléique et un procédé de diagnose de tumeurs
|
|
AU7634301A
(en)
*
|
2000-05-26 |
2001-12-03 |
Bayer Aktiengesellschaft |
Regulation of human p78-like serine/threonine kinase
|
|
DE10027170A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Humanes PEM als Target für die Fertilitätskontrolle
|
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001094385A2
(fr)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Regulation du recepteur couple a la proteine humaine g de type hm74
|
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
CA2411278A1
(fr)
*
|
2000-06-09 |
2001-12-20 |
Corixa Corporation |
Compositions et procedes pour la therapie et le diagnostic du cancer du colon
|
|
EP1290193A2
(fr)
*
|
2000-06-16 |
2003-03-12 |
Incyte Genomics, Inc. |
Proteine phosphatase
|
|
EP2077276A1
(fr)
*
|
2000-06-23 |
2009-07-08 |
Genentech, Inc. |
Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogenèse
|
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
|
CA2412256A1
(fr)
*
|
2000-06-27 |
2002-01-03 |
Curagen Corporation |
Nouveaux polynucleotides et polypeptides codes par ceux-ci
|
|
WO2002000939A2
(fr)
|
2000-06-28 |
2002-01-03 |
Diadexus, Inc. |
Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon
|
|
WO2002002761A2
(fr)
*
|
2000-06-30 |
2002-01-10 |
Millennium Pharmaceuticals, Inc. |
57658, nouvelle uridine kinase humaine et utilisations correspondantes
|
|
WO2002004510A2
(fr)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Proteines liant le nucleotide guanine
|
|
EP1313854A2
(fr)
*
|
2000-07-07 |
2003-05-28 |
Incyte Genomics, Inc. |
Transporteurs et canneaux d'ion
|
|
WO2002006326A2
(fr)
*
|
2000-07-14 |
2002-01-24 |
Millennium Pharmaceuticals, Inc. |
62088, un nouveau membre humain de la famille nucleoside phosphatase, et utilisations de ce dernier
|
|
US20030171324A1
(en)
*
|
2000-07-18 |
2003-09-11 |
Shyam Ramakrishnan |
Regulation of human desc1-like serine protease
|
|
WO2002006318A2
(fr)
|
2000-07-18 |
2002-01-24 |
Board Of Regents, The University Of Texas System |
Procedes et compositions permettant de stabiliser des microtubules et des filaments intermediaires dans des cellules de muscle strie
|
|
US20060252034A1
(en)
*
|
2000-07-25 |
2006-11-09 |
Klaus Duecker |
Novel protein containing ring finger domaine r1p4
|
|
AU2001277200A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-cad protein and related reagents and methods of use thereof
|
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
|
EP1657254A3
(fr)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer
|
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
|
EP1315431A1
(fr)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
|
|
AU2001283062A1
(en)
|
2000-08-02 |
2002-02-13 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
|
AU2001288231A1
(en)
|
2000-08-04 |
2002-02-18 |
Zymogenetics Inc. |
Human secreted protein, zzp1
|
|
US6943245B2
(en)
|
2000-08-10 |
2005-09-13 |
Board Of Regents, The University Of Texas System |
Tumor suppressor CAR-1
|
|
CA2418266A1
(fr)
*
|
2000-08-11 |
2002-02-21 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Nouvelles proteines mekk
|
|
EP1326985A1
(fr)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification d'un gene d'acetyltransferase n-terminale humaine
|
|
AU2001285109A1
(en)
*
|
2000-08-21 |
2002-03-04 |
Incyte Genomics, Inc. |
Microtubule-associated proteins and tubulins
|
|
WO2002016586A2
(fr)
|
2000-08-21 |
2002-02-28 |
Bristol-Myers Squibb Company |
Nouvel homologue d'adenosine deaminase
|
|
AU2001284655A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
|
EP1313850B1
(fr)
|
2000-08-28 |
2008-08-06 |
Agensys, Inc. |
Acide nucleique et proteine correspondante denommes 85p1b3 utilises dans le traitement et la detection de cancers
|
|
AU2001232835A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Human Genome Sciences, Inc. |
18 human secreted proteins
|
|
AU2001284176A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
US20020146800A1
(en)
*
|
2000-08-30 |
2002-10-10 |
Curtis Rory A.J. |
48921, a novel human GTP releasing factor and uses therefor
|
|
WO2002018552A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation d'enzyme humaine de type aminotransferase
|
|
WO2002018573A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
Nouveau transporteur humain de sulfate: la proteine 54370, et utilisations associees
|
|
WO2002018582A2
(fr)
*
|
2000-08-31 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
62112, nouvelle deshydrogenase humaine et ses utilisations
|
|
AU8881201A
(en)
*
|
2000-09-05 |
2002-03-22 |
Amgen Inc |
Tnf receptor-like molecules and uses thereof
|
|
WO2002020754A2
(fr)
*
|
2000-09-05 |
2002-03-14 |
Incyte Genomics, Inc. |
Molecules utilisees a des fins diagnostiques et therapeutiques
|
|
AU2001288999A1
(en)
*
|
2000-09-08 |
2002-03-22 |
Millennium Pharmaceuticals, Inc. |
38646, a guanine nucleotide exchange factor and uses therefor
|
|
US6372468B1
(en)
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
|
US20040048245A1
(en)
*
|
2000-10-05 |
2004-03-11 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
|
EP1402010A2
(fr)
*
|
2000-10-11 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
Nouvel element de la famille des phosphatases humaines a double specificite, appele 8843, et utilisation de ce dernier
|
|
US20020064831A1
(en)
*
|
2000-10-12 |
2002-05-30 |
The Texas A&M University System |
Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use
|
|
MXPA03003151A
(es)
*
|
2000-10-13 |
2003-08-19 |
Eos Biotechnology Inc |
Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata.
|
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
|
AU2002249787A1
(en)
|
2000-10-25 |
2002-08-19 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
|
WO2002036781A2
(fr)
*
|
2000-10-31 |
2002-05-10 |
Bayer Aktiengesellschaft |
Regulation de la glutathione-s-transferase humaine
|
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
|
WO2002040672A2
(fr)
|
2000-11-20 |
2002-05-23 |
Diadexus, Inc. |
Compositions et methodes relatives a des genes et des proteines specifiques aux seins
|
|
WO2002081667A2
(fr)
*
|
2000-12-05 |
2002-10-17 |
Incyte Genomics, Inc. |
Ligases
|
|
JP2004535765A
(ja)
|
2000-12-07 |
2004-12-02 |
カイロン コーポレイション |
前立腺癌においてアップレギュレートされた内因性レトロウイルス
|
|
EP1339845A2
(fr)
|
2000-12-07 |
2003-09-03 |
ZymoGenetics, Inc. |
Proteine associee au complement adipocyte zacrp3x2
|
|
CA2439800A1
(fr)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Proteines kinases humaines isolees, molecules d'acide nucleique codant des proteines kinases humaines et utilisations associees
|
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
ES2265389T3
(es)
|
2000-12-22 |
2007-02-16 |
Bristol-Myers Squibb Company |
Proteina humana que contiene repeticiones ricas en leucina expresada predominantemente en el intestino delgado, hlrrsi1.
|
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US6423521B1
(en)
*
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
WO2002053591A1
(fr)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation
|
|
WO2002053754A2
(fr)
*
|
2001-01-08 |
2002-07-11 |
Lexicon Genetics Incorporated |
Nouvelle protease humaine et polynucleotides codant cette derniere
|
|
AU2002243750A1
(en)
*
|
2001-01-30 |
2002-08-12 |
Regeneron Pharmaceuticals, Inc. |
Novel nucleic acid and polypeptide molecules
|
|
WO2002098917A2
(fr)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines
|
|
EP1637601A3
(fr)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Protéines , polynucléotides codant pour ces protéines et procédés d'utilisation
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
EP1434783A4
(fr)
*
|
2001-03-16 |
2006-06-07 |
Lilly Co Eli |
Proteines de mammiferes lp et reactifs associes
|
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
|
WO2002083921A2
(fr)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
|
|
EP1383922A4
(fr)
|
2001-04-10 |
2005-03-30 |
Agensys Inc |
Acide nucleique et proteine correspondante intitule 158p3d2 utiles dans le traitement et la detection du cancer
|
|
EP1573022B1
(fr)
|
2001-04-10 |
2011-06-08 |
Agensys, Inc. |
Acide nucleique et proteine correspondante intitulee 184p1e2, utilises dans le traitement et la detection de cancers
|
|
WO2002086113A2
(fr)
*
|
2001-04-24 |
2002-10-31 |
Isis Innovation Ltd |
Enzyme et marqueur snp pour le depistage d'une maladie
|
|
CA2445309A1
(fr)
*
|
2001-04-24 |
2002-11-07 |
Otsuka Pharmaceutical Co., Ltd. |
Peptide de liaison a des anticorps de la maladie de crohn et methode d'examen de ladite maladie
|
|
US20050158719A1
(en)
|
2001-05-07 |
2005-07-21 |
Yasufumi Sato |
Polypeptide serving as angiogenic marker and dna thereof
|
|
AU2002314048A1
(en)
*
|
2001-05-09 |
2002-11-18 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
AU2002311535A1
(en)
*
|
2001-06-26 |
2003-01-08 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
|
US20030120040A1
(en)
|
2001-06-29 |
2003-06-26 |
Genentech, Inc. |
Secreted and Transmembrane polypeptides and nucleic acids encoding the same
|
|
GB2399086A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ4
|
|
JP2005504546A
(ja)
*
|
2001-08-17 |
2005-02-17 |
インサイト・ゲノミックス・インコーポレイテッド |
細胞内シグナル伝達分子
|
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
WO2003023063A1
(fr)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Methode d'estimation du risque d'apparition de diabetes
|
|
WO2003040369A2
(fr)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
|
WO2003025175A2
(fr)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
|
JP2005534279A
(ja)
|
2001-09-28 |
2005-11-17 |
ブリガム ヤング ユニバーシティ |
新規なシクロオキシゲナーゼ変異体とその使用方法
|
|
EP1439225A4
(fr)
|
2001-10-04 |
2005-10-26 |
Kansai Tech Licensing Org Co |
Promoteur du gene dr5 et promoteur du gene siah-1
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
WO2003031607A1
(fr)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation de deshydrogenase/reductase des chaines courtes humaine
|
|
EP1310552B1
(fr)
|
2001-11-09 |
2007-06-13 |
Proteologics, Inc. |
Acides nucléiques et polypeptides Posh et procédés associés
|
|
WO2003054146A2
(fr)
|
2001-11-14 |
2003-07-03 |
Northwestern University |
Auto-assemblage et mineralisation de nanofibres de peptide amphiphile
|
|
US20050053940A1
(en)
*
|
2001-11-21 |
2005-03-10 |
Joh-E Ikeda |
Huntington's disease gene transcriptional factors
|
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
|
WO2003051911A2
(fr)
*
|
2001-12-19 |
2003-06-26 |
Genset S.A. |
Polypeptides et polynucleotides gmg-5 et utilisations de ceux-ci
|
|
JP2003245084A
(ja)
*
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
|
DE10163467A1
(de)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
Protein 24B2 und zugrundliegende DNA-Sequenz
|
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
|
AU2003202543A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Bayer Aktiengesellschaft |
Human phosphatidic acid phosphatase type 2-like protein
|
|
WO2003060109A2
(fr)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Regulation d'une subtilase humaine
|
|
WO2003059948A1
(fr)
*
|
2002-01-15 |
2003-07-24 |
Medigene Ag |
Gene-2 associe a la myocardiopathie dilatee (dcmag-2) : inducteur cytoplasmique du remodelage sarcomerique de cardiomyocytes
|
|
WO2003062429A1
(fr)
*
|
2002-01-23 |
2003-07-31 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouvelle serine protease
|
|
WO2003070749A2
(fr)
|
2002-02-15 |
2003-08-28 |
Northwestern University |
Auto-assemblage de nanofibres amphiphiles peptidiques dans des conditions physiologiques
|
|
EP1338609A1
(fr)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
Un outre récepteur KDR et son utilisation
|
|
WO2003076645A2
(fr)
*
|
2002-03-05 |
2003-09-18 |
Applera Corporation |
Proteines transporteuses humaines isolees, molecules d'acide nucleique codant celles-ci, et utilisations associees
|
|
WO2003074557A1
(fr)
*
|
2002-03-06 |
2003-09-12 |
Oxford Glycosciences (Uk) Ltd |
Nouvelle proteine associée à la malignité de lymphocyte b
|
|
EP2258872B1
(fr)
|
2002-03-13 |
2013-08-14 |
Genomic Health, Inc. |
Profilage de l'expression génétique dans des tissus de tumeurs prélevées par biopsie
|
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
|
WO2003078466A1
(fr)
*
|
2002-03-19 |
2003-09-25 |
Tanabe Seiyaku Co., Ltd. |
Recepteurs couples a la proteine g et genes correspondants
|
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
CA2413475C
(fr)
|
2002-04-25 |
2010-07-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Expression de zap-70 en tant que marqueur de la leucemie chronique lymphoide/du lymphome a petits lymphocytes (lcl/lpl)
|
|
JP2004041003A
(ja)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
新規タンパク質、そのｄｎａおよびその用途
|
|
EP1507553A2
(fr)
|
2002-05-29 |
2005-02-23 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Proteines specifiques du pancreas
|
|
WO2003101401A2
(fr)
|
2002-06-03 |
2003-12-11 |
Chiron Corporation |
Utilisation de nrg4, ou d'inhibiteurs de nrg4, dans le traitement du cancer du colon et du pancreas
|
|
BRPI0311822B8
(pt)
|
2002-06-06 |
2021-05-25 |
Oncotherapy Science Inc |
composição farmacêutica para o tratamento de câncer
|
|
EP2302039A1
(fr)
|
2002-06-13 |
2011-03-30 |
Novartis Vaccines and Diagnostics, Inc. |
Particules de type virus comprenant le polypeptide gag de HML-2
|
|
CA2493263A1
(fr)
*
|
2002-07-22 |
2004-01-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouveau gene associe a l'arthrite rhumatoide
|
|
WO2004016790A1
(fr)
|
2002-08-14 |
2004-02-26 |
National Institute Of Advanced Industrial Science And Technology |
Nouvelles n-acetylgalactosamine transferases et acides nucleiques codant ces transferases
|
|
US20040081653A1
(en)
*
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
|
WO2004020662A2
(fr)
*
|
2002-08-27 |
2004-03-11 |
Epigenomics Ag |
Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires
|
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
|
JP4679149B2
(ja)
|
2002-09-30 |
2011-04-27 |
オンコセラピー・サイエンス株式会社 |
ヒト膵癌に関連する遺伝子およびポリペプチド
|
|
AU2003294696A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
CA2506066A1
(fr)
|
2002-11-15 |
2004-06-03 |
Genomic Health, Inc. |
Etablissement de profils d'expressions genetique du cancer a recepteur de facteur de croissance epidermique positif
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
US7326768B2
(en)
|
2003-02-05 |
2008-02-05 |
Juan Saus |
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
|
EP1445614A1
(fr)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Méthodes d'évaluation in vitro de l'état de progression d'un virus HIV chez un individu
|
|
US7074891B2
(en)
*
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
|
PT1597391E
(pt)
|
2003-02-20 |
2008-12-19 |
Genomic Health Inc |
Utilização de arn intrónico para medir a expressão genética
|
|
CA2517953A1
(fr)
*
|
2003-03-04 |
2004-09-16 |
Astellas Pharma Inc. |
Nouveau gene associe a des conditions fibreuses
|
|
PT2248899E
(pt)
*
|
2003-03-19 |
2015-09-23 |
Biogen Ma Inc |
Proteína de ligação do receptor nogo
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
CA3061769C
(fr)
|
2003-06-24 |
2021-10-26 |
Genomic Health, Inc. |
Methodes pour prevoir la probabilite de survie a long terme d'un patienthumain atteint d'un cancer du sein canalaire invasif avec recepteur des oestrogenes positif, sans atteinte des ganglions, sans recurrence du cancer du sein
|
|
WO2005008213A2
(fr)
|
2003-07-10 |
2005-01-27 |
Genomic Health, Inc. |
Algorithme de profile d'expression et test du pronostic du cancer
|
|
EP2311468B1
(fr)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gène surexprimé dans le cancer
|
|
US20050136434A1
(en)
*
|
2003-08-12 |
2005-06-23 |
Mai Xu |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
WO2005026314A2
(fr)
*
|
2003-09-10 |
2005-03-24 |
Japan Science And Technology Agency |
Groupe de genes exprimes de facon differentielle dans des cellules de sang peripherique ainsi que procede de diagnostic et procede d'analyse mettant en oeuvre ce groupe
|
|
WO2005032584A2
(fr)
*
|
2003-10-02 |
2005-04-14 |
Glaxosmithkline Biologicals S.A. |
Composes
|
|
RU2006114694A
(ru)
|
2003-10-03 |
2007-11-10 |
Брихэм Энд Уимен`З Хоспитал (Us) |
Tim-3-полипептиды
|
|
WO2005040791A2
(fr)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr)
|
|
WO2005051994A2
(fr)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Facteur de necrose tumorale ztnf11
|
|
CN102225964A
(zh)
*
|
2003-12-05 |
2011-10-26 |
西北大学 |
自组装的肽两亲物和用于生长因子传递的相关方法
|
|
KR20070000438A
(ko)
|
2003-12-23 |
2007-01-02 |
게노믹 헬쓰, 인코포레이티드 |
단편화 ｒｎａ의 범용적 증폭
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
ES2663248T3
(es)
*
|
2004-03-02 |
2018-04-11 |
The Johns Hopkins University |
Mutaciones del gen de PIK3CA en cánceres humanos
|
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
WO2005090569A1
(fr)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations
|
|
EP2289911A3
(fr)
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Utilisation thérapeutique du facteur de croissance nsg33
|
|
EP1737980A2
(fr)
|
2004-04-09 |
2007-01-03 |
Fondazione IRCCS Istituto Nazionale dei Tumori |
Marqueurs d'expression genique permettant de predire la reponse a la chimiotherapie
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
WO2005118832A2
(fr)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl)
|
|
ES2395094T3
(es)
|
2004-06-24 |
2013-02-08 |
Biogen Idec Ma Inc. |
Tratamiento de afecciones que implican la desmielinización
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
ES2328261T3
(es)
*
|
2004-08-05 |
2009-11-11 |
Toagosei Co., Ltd. |
Peptido epitopico de un anticuerpo de la enfermedad de crohn y reactivo para ensayar la enfermedad de crohn.
|
|
DK1815014T3
(da)
|
2004-11-05 |
2012-06-18 |
Genomic Health Inc |
Molekylære indikatorer for brystcancerprognose og forudsigelse af behandlingsrespons
|
|
JP5020088B2
(ja)
|
2004-11-05 |
2012-09-05 |
ジェノミック ヘルス， インコーポレイテッド |
遺伝子発現マーカーを使用する、化学療法に対する反応の予測
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
CN102746404B
(zh)
|
2004-11-12 |
2016-01-20 |
赞科股份有限公司 |
对FcRn的结合被改变的Fc变体
|
|
KR20070108555A
(ko)
|
2005-03-04 |
2007-11-12 |
노오쓰웨스턴 유니버시티 |
혈관신생 헤파린 결합 펩티드 양친매성 화합물
|
|
EP1880005B1
(fr)
*
|
2005-05-13 |
2012-11-07 |
Centre National de la Recherche Scientifique |
Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques
|
|
MX2008000253A
(es)
|
2005-07-08 |
2008-04-02 |
Biogen Idec Inc |
Anticuerpos de sp35 y usos de los mismos.
|
|
WO2007014338A2
(fr)
*
|
2005-07-26 |
2007-02-01 |
Siemens Medical Solutions Diagnostics |
Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire
|
|
US8207128B2
(en)
*
|
2005-09-28 |
2012-06-26 |
Supadelixir Inc. |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
|
EP1790664A1
(fr)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
|
DE602005023550D1
(de)
|
2005-12-14 |
2010-10-21 |
Licentia Ltd |
Verwendungen eines neurotrophischen Faktors
|
|
WO2008003656A2
(fr)
*
|
2006-07-03 |
2008-01-10 |
Exonhit Therapeutics Sa |
Produits de la transcription spécifiques de la prostate et leur utilisation pour des thérapeutiques et des diagnostics du cancer de la prostate
|
|
WO2008030559A2
(fr)
*
|
2006-09-08 |
2008-03-13 |
Corixa Corporation |
Procédés, compositions, et kits de détection et de surveillance d'un cancer du colon
|
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
GB0805159D0
(en)
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
EP2565204B1
(fr)
*
|
2007-07-27 |
2015-10-07 |
immatics biotechnologies GmbH |
Nouveaux épitopes immunogènes pour l'immunothérapie
|
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
|
WO2009034661A1
(fr)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Procédé de diagnostic et induction d'une résistance à un virus
|
|
EP2216340B1
(fr)
|
2007-10-17 |
2012-12-12 |
Universidad De Córdoba |
Isoformes du récepteur de la somatostatine humaine de type 5 produites par traitement alternatif et paires d'oligonucléotides permettant de les détecter par pcr
|
|
SI2808343T1
(sl)
|
2007-12-26 |
2019-10-30 |
Xencor Inc |
Fc-variante s spremenjeno vezavo na FcRn
|
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
WO2009115612A1
(fr)
*
|
2008-03-21 |
2009-09-24 |
Universiteit Hasselt |
Biomarqueurs de la polyarthrite rhumatoïde
|
|
DK2982695T3
(da)
|
2008-07-09 |
2019-05-13 |
Biogen Ma Inc |
Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
|
|
CA2730710C
(fr)
|
2008-07-24 |
2021-06-08 |
Nsgene A/S |
Utilisation therapeutique d'un facteur de croissance, metrnl
|
|
DK2172211T3
(en)
|
2008-10-01 |
2015-02-16 |
Immatics Biotechnologies Gmbh |
Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
|
|
AU2009313808B2
(en)
|
2008-11-14 |
2013-05-16 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
|
WO2010062960A2
(fr)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d’une maladie intestinale inflammatoire
|
|
CA2745849A1
(fr)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Nouveau variant retroviral endogene humain d'erv3 et utilisations de celui-ci pour diagnostiquer le cancer des ovaires
|
|
KR20120012811A
(ko)
|
2009-04-13 |
2012-02-10 |
노오쓰웨스턴 유니버시티 |
신규한 연골 재생용 펩티드-기반 스카폴드 및 이들의 사용 방법
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
EP2528615B1
(fr)
*
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Agents polypeptidiques techniques pour la neutralisation de la grippe à large spectre ciblée
|
|
PT2621526T
(pt)
|
2010-09-29 |
2018-08-02 |
Seattle Genetics Inc |
Conjugados de anticorpo com fármaco (adc) que se ligam a proteínas 191pad12
|
|
CN103269708A
(zh)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
|
DK2651430T3
(en)
|
2010-12-14 |
2018-08-27 |
Hananja Ehf |
Biological activity of placental protein 13
|
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
|
AR088699A1
(es)
*
|
2011-11-09 |
2014-06-25 |
Sanofi Sa |
Diacilglicerol lipasa y usos de la misma
|
|
EP2844667B1
(fr)
|
2012-04-30 |
2018-05-30 |
Biocon Limited |
Protéines de fusion ciblées/immunomodulatrices et leurs procédés de fabrication
|
|
WO2013167153A1
(fr)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
|
WO2013173364A2
(fr)
|
2012-05-14 |
2013-11-21 |
Biogen Idec Ma Inc. |
Antagonistes de lingo-2 pour le traitement d'affections impliquant des neurones moteurs
|
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
|
WO2014075788A1
(fr)
|
2012-11-13 |
2014-05-22 |
Biontech Ag |
Agents de traitement de maladies cancéreuses exprimant claudine
|
|
WO2014127785A1
(fr)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
|
US9023353B2
(en)
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
|
WO2014146672A1
(fr)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer
|
|
CN112870368A
(zh)
|
2013-03-27 |
2021-06-01 |
西达-赛奈医疗中心 |
通过抑制tl1a的功能和相关信号传导途径来减轻并逆转纤维化和炎症
|
|
DK3019619T3
(da)
|
2013-07-11 |
2021-10-11 |
Modernatx Inc |
Sammensætninger, der omfatter syntetiske polynukleotider, som koder for crispr-beslægtede proteiner, og syntetiske sgrna'er, og anvendelsesfremgangsmåder
|
|
EP3022295A4
(fr)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature de la voie de signalisation de tl1a (tnfsf15)
|
|
CA3214529A1
(fr)
|
2013-09-25 |
2015-04-02 |
Cytomx Therapeutics, Inc. |
Substrats pour metalloproteinases matricielles et autres fragments clivables et leurs procedes d'utilisation
|
|
WO2015050158A1
(fr)
*
|
2013-10-01 |
2015-04-09 |
国立大学法人三重大学 |
Vaccin d'induction de lymphocytes t contenant une séquence interépitope favorisant une présentation d'antigène
|
|
AU2015210862B2
(en)
|
2014-01-31 |
2020-04-23 |
Cytomx Therapeutics, Inc |
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
|
|
MX2017009038A
(es)
|
2015-01-08 |
2017-10-25 |
Biogen Ma Inc |
Antagonistas de proteina 1 de interacción con el receptor de nogo que contiene el dominio de inmunoglobulina y repeticiones ricas en leucina (lingo-1) y usos para el tratamiento de trastornos desmielinizantes.
|
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
|
EP3307070A4
(fr)
*
|
2015-06-12 |
2019-01-02 |
Emory University |
Compositions de croissance et de survie pour des cellules capables de produire des anticorps et procédés associés
|
|
PT3344776T
(pt)
|
2015-09-04 |
2021-08-03 |
Synthetic Genomics Inc |
Microorganismos recombinantes de algas com aumento de produtividade
|
|
WO2017161342A1
(fr)
|
2016-03-17 |
2017-09-21 |
Cedars-Sinai Medical Center |
Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2
|
|
JP2019513025A
(ja)
*
|
2016-03-29 |
2019-05-23 |
ヴァルキリー セラピューティクス インコーポレイテッド |
染色体構造維持−１の発現の調節
|
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
|
EP3508499A1
(fr)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Anticorps ciblant et d'autres modulateurs d'un gène d'immunoglobuline associé à une résistance contre des réponses immunitaires antitumorales et leurs utilisations
|
|
AU2020311579A1
(en)
|
2019-07-05 |
2022-02-03 |
Iomx Therapeutics Ag |
Antibodies binding IgC2 of IGSF11 (VSIG3) and uses thereof
|
|
WO2021083958A1
(fr)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Nouveaux peptides induisant la satiété
|
|
WO2021228999A1
(fr)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Épitopes néo-antigéniques associés à des mutations sf3b1
|
|
EP4175668A1
(fr)
|
2020-07-06 |
2023-05-10 |
iOmx Therapeutics AG |
Anticorps de liaison à l'igv d'igsf11 (vsig3) et leurs utilisations
|
|
AU2022209669A1
(en)
*
|
2021-01-21 |
2023-08-10 |
Erasmus University Medical Center Rotterdam |
T cells for use in therapy
|
|
EP4294403A1
(fr)
*
|
2021-02-18 |
2023-12-27 |
Beren Therapeutics P.B.C. |
Méthodes de traitement de l'hypercholestérolémie familiale hétérozygote et homozygote avec des cyclodextrines
|
|
WO2023225602A1
(fr)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Polypeptides de liaison au récepteur de l'interleukine-18 et leurs utilisations
|